Dr. Gilbert Padula is Summa Health's new medical director for the Summa Health Cancer Institute, starting Jan. 30.
He was also named the Vincent and Nancy DiGirolamo Endowed Chair in Oncology. Padula replaces Dr. R. Douglas Trochelman, who wanted to spend more time clinically and is continuing with Summa Health as a medical oncologist.
Since 2002, Padula had served as president of Grand Rapids Radiation Oncology at the Mercy Health Lacks Cancer Center. For the past three years, he's also been medical director for technology and innovation at the center in Michigan, according to a news release
"We are thrilled to welcome Dr. Padula to the Summa Health family," Dr. Vivian von Gruenigen, chief medical officer for the health system, said in a statement. "He brings a wealth of talent and expertise to our outstanding team of cancer professionals. We look forward to his leadership."
He was a lecturer and speaker for many organizations across Michigan and has held leadership roles in many professional associations, according to the release.
While he was in Michigan, he served as the principal investigator for the Cancer Research Consortium of West Michigan, which raised nearly $10 million in five years for cancer research.
Padula received a bachelor of science degree from the University of Michigan, completed his post-baccalaureate premedical studies at Columbia University and earned his medical degree from the Michigan State University College of Human Medicine. He completed his internship at St. Joseph Mercy Hospital in Ann Arbor, Mich., and his residency at Memorial Sloan Kettering Cancer Center in New York City.
"Summa Health names new medical director for its cancer institute" originally appeared in Crain's Cleveland Business.